Adrienne Graves, Director at Akorn, holds 36.00K shares in Ocular Therapeutix (Ticker: OCUL), holds 0.00 shares in IVERIC bio (Ticker: ISEE), holds 77.70K shares in Akorn (Ticker: AKRXQ).
Adrienne Graves latest transaction was an Uninformative Buy of ―.
What was Adrienne Graves's most profitable transaction?
Adrienne Graves’s most profitable transaction was an Informative Sell of AKRXQ stock on December 12, 2014. The return on the trade was 16.10%.
What is Adrienne Graves's role in Akorn?
Adrienne Graves's role in Akorn is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.